Patent
High affinity RNA ligands of basic fibroblast growth factor
Nebojsa Janjic,Larry Gold +1 more
- 06 Jul 2004
66
TL;DR: In this article, the identification and preparation of nucleic acid ligand solutions to basic fibroblast growth factor (bFGF) was described, which are inhibitors of bFGF and 2′-amino-modified RNA ligands to BGF.
read more
Abstract: Methods are described for the identification and preparation of nucleic acid ligand solutions to basic fibroblast growth factor (bFGF). Included in the invention are nucleic acid ligands to bFGF which are inhibitors of bFGF and 2′-amino-modified RNA ligands to bFGF.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Method for purification and identification of sperm cells
Glenn Sanders,Evaldas Katilius,Larry Gold +2 more
- 15 Jun 2012
TL;DR: In this paper, the authors describe the isolation, identification and purification of aptamers having sufficiently high affinity and specificity to capture and immobilize intact sperm cells in the presence of female epithelial cells and other non-sperm semen components.
4
Patent
Methods for identifying nucleic acid ligands
Vladimir Leo Gilman
- 07 May 2013
TL;DR: In this paper, the authors present methods for identifying nucleic acid ligands of a target molecule from a candidate mixture of nucleic acids, including contacting at least one target molecule with a candidate Mixture of NAs, in which the NAs have different affinities for the target molecule.
4
Patent
Aptamers comprising CPG motifs
David Epstein,Dilara Grate,Martin Stanton,John L. Diener,Charles Wilson,Thomas G. McCauley,Desouza Errol +6 more
- 21 Apr 2004
TL;DR: In this article, materials and methods for producing and using aptamers useful as oncology therapeutics capable of binding to PDGF, PDGF isoforms, PD GF receptor, VEGF, and VEGFs receptor or any combination thereof with great affinity and specificity are provided.
1
Patent
Nucleic acid ligands against infectious prions
Vladimir Leo Gilman
- 03 Nov 2009
TL;DR: In this paper, a method for diagnosing transmissible spongiform encephalopathy disease in a subject is described. But the method is based on the results of the contacting step.
References
•Book
Peptide Growth Factors and Their Receptors
健一 新井,James F. Battey,Michael B. Sporn,Anita B. Roberts +3 more
- 31 Dec 1991
TL;DR: A comprehensive survey of the chemistry and biology of peptide growth factors is presented in this paper, where the peptides described here are of fundamental importance for understanding the behavior of all cells, and they will be of major importance in the practice of clinical medicine in the years to come.
1.3K
Patent
Methods for identifying nucleic acid ligands
Larry Gold,Craig Tuerk +1 more
- 17 Aug 1992
TL;DR: The SELEX (Systematic Evolution of Ligands by EXponential Enrichment) method as discussed by the authors was proposed for the identification of nucleic acid ligands, where a candidate mixture of single stranded nucleic acids having regions of randomized sequence is contacted with a target compound and those nucleic amino acids having an increased affinity to the target are partitioned from the remainder of the candidate mixture.
797
Patent
Nucleic acid ligands
Larry Gold,Craig Tuerk +1 more
- 10 Jun 1991
TL;DR: The Systematic Evolution of Ligands by Exponential enrichment (SELEX) method as mentioned in this paper was proposed to identify the ligand components of the nucleic acid antibodies by the method of the invention referred to as SELEX, wherein a candidate mixture of nucleic acids are iteratively enriched in high affinity nucleic amino acid and amplified for further partitioning.
770
Patent
Sugar modified oligonucleotides that detect and modulate gene expression.
Phillip Dan Cook,Andrew Mamoro Kawasaki +1 more
- 12 Aug 1991
TL;DR: In this paper, the authors proposed a method for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins, such as HIV, herpes virus, papillomavirus and other infections.
708
Patent
Systematic evolution of ligands by exponential enrichment: tissue SELEX
Larry Gold,Bruce E. Eaton,Drew Smith,Matthew Wecker,Kirk B. Jensen +4 more
- 01 May 1996
TL;DR: In this article, high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissues targets, and the methods for obtaining such ligands are described.
682